343 related articles for article (PubMed ID: 24928666)
1. Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities.
Ndeffo Mbah ML; Gilbert JA; Galvani AP
Epidemics; 2014 Jun; 7():22-7. PubMed ID: 24928666
[TBL] [Abstract][Full Text] [Related]
2. Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women.
Ndeffo Mbah ML; Poolman EM; Atkins KE; Orenstein EW; Meyers LA; Townsend JP; Galvani AP
PLoS Negl Trop Dis; 2013; 7(8):e2346. PubMed ID: 23936578
[TBL] [Abstract][Full Text] [Related]
3. Mapping Schistosoma haematobium for Novel Interventions against Female Genital Schistosomiasis and Associated HIV Risk in KwaZulu-Natal, South Africa.
Livingston M; Pillay P; Zulu SG; Sandvik L; Kvalsvig JD; Gagai S; Galappaththi-Arachchige HN; Kleppa E; Ndhlovu P; Vennervald B; Gundersen SG; Taylor M; Kjetland EF
Am J Trop Med Hyg; 2021 May; 104(6):2055-2064. PubMed ID: 33939629
[TBL] [Abstract][Full Text] [Related]
4. Impact of praziquantel mass drug administration campaign on prevalence and intensity of Schistosoma haemamtobium among school children in Bahi district, Tanzania.
Chaula SA; Tarimo DS
Tanzan J Health Res; 2014 Jan; 16(1):1-8. PubMed ID: 26867266
[TBL] [Abstract][Full Text] [Related]
5. Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa.
Gurarie D; Yoon N; Li E; Ndeffo-Mbah M; Durham D; Phillips AE; Aurelio HO; Ferro J; Galvani AP; King CH
Parasit Vectors; 2015 Oct; 8():529. PubMed ID: 26489408
[TBL] [Abstract][Full Text] [Related]
6. Schistosomiasis in school-age children in Burkina Faso after a decade of preventive chemotherapy.
Ouedraogo H; Drabo F; Zongo D; Bagayan M; Bamba I; Pima T; Yago-Wienne F; Toubali E; Zhang Y
Bull World Health Organ; 2016 Jan; 94(1):37-45. PubMed ID: 26769995
[TBL] [Abstract][Full Text] [Related]
7. Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa.
Ndeffo Mbah ML; Skrip L; Greenhalgh S; Hotez P; Galvani AP
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3234. PubMed ID: 25329403
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
[TBL] [Abstract][Full Text] [Related]
9. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP
Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
12. Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia.
Mwanakasale V; Vounatsou P; Sukwa TY; Ziba M; Ernest A; Tanner M
Am J Trop Med Hyg; 2003 Oct; 69(4):420-8. PubMed ID: 14640503
[TBL] [Abstract][Full Text] [Related]
13. Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study.
Kokaliaris C; Garba A; Matuska M; Bronzan RN; Colley DG; Dorkenoo AM; Ekpo UF; Fleming FM; French MD; Kabore A; Mbonigaba JB; Midzi N; Mwinzi PNM; N'Goran EK; Polo MR; Sacko M; Tchuem Tchuenté LA; Tukahebwa EM; Uvon PA; Yang G; Wiesner L; Zhang Y; Utzinger J; Vounatsou P
Lancet Infect Dis; 2022 Jan; 22(1):136-149. PubMed ID: 34863336
[TBL] [Abstract][Full Text] [Related]
14. Cervicovaginal Immune Activation in Zambian Women With Female Genital Schistosomiasis.
Sturt AS; Webb EL; Patterson C; Phiri CR; Mweene T; Kjetland EF; Mudenda M; Mapani J; Mutengo MM; Chipeta J; van Dam GJ; Corstjens PLAM; Ayles H; Hayes RJ; Hansingo I; Cools P; van Lieshout L; Helmby H; McComsey GA; Francis SC; Bustinduy AL
Front Immunol; 2021; 12():620657. PubMed ID: 33737927
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa.
Ndeffo Mbah ML; Kjetland EF; Atkins KE; Poolman EM; Orenstein EW; Meyers LA; Townsend JP; Galvani AP
Proc Natl Acad Sci U S A; 2013 May; 110(19):7952-7. PubMed ID: 23589884
[TBL] [Abstract][Full Text] [Related]
16. Are health education interventions effective for the control and prevention of urogenital schistosomiasis in sub-Saharan Africa? A systematic review.
Price A; Verma A; Welfare W
Trans R Soc Trop Med Hyg; 2015 Apr; 109(4):239-44. PubMed ID: 25669840
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa.
Kabuyaya M; Chimbari MJ; Manyangadze T; Mukaratirwa S
Infect Dis Poverty; 2017 Apr; 6(1):83. PubMed ID: 28385154
[TBL] [Abstract][Full Text] [Related]
18. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
[TBL] [Abstract][Full Text] [Related]
19. Urogenital schistosomiasis in Cabo Delgado, northern Mozambique: baseline findings from the SCORE study.
Phillips AE; Gazzinelli-Guimarães PH; Aurelio HO; Dhanani N; Ferro J; Nala R; Deol A; Fenwick A
Parasit Vectors; 2018 Jan; 11(1):30. PubMed ID: 29316983
[TBL] [Abstract][Full Text] [Related]
20. HIV and Schistosoma haematobium prevalences correlate in sub-Saharan Africa.
Mbah MLN; Poolman EM; Drain PK; Coffee MP; van der Werf MJ; Galvani AP
Trop Med Int Health; 2013 Oct; 18(10):1174-1179. PubMed ID: 23952297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
